POLN
Basic information
Region (hg38): 4:2071918-2242121
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 46 | 56 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 32 | 32 | ||||
Total | 0 | 0 | 78 | 8 | 3 |
Variants in POLN
This is a list of pathogenic ClinVar variants found in the POLN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-2072130-G-A | not specified | Uncertain significance (Jun 30, 2023) | ||
4-2072170-A-T | not specified | Uncertain significance (Jan 08, 2024) | ||
4-2072203-C-G | not specified | Uncertain significance (May 25, 2023) | ||
4-2072230-C-T | not specified | Uncertain significance (Jul 30, 2023) | ||
4-2072272-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
4-2072975-TG-T | Benign (Jan 18, 2019) | |||
4-2072981-T-A | not specified | Uncertain significance (Dec 22, 2023) | ||
4-2073010-C-T | not specified | Uncertain significance (Jun 30, 2023) | ||
4-2073026-A-T | not specified | Uncertain significance (Feb 10, 2022) | ||
4-2075463-G-A | not specified | Uncertain significance (Jul 06, 2022) | ||
4-2075515-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
4-2081674-C-T | Malignant tumor of prostate | Uncertain significance (-) | ||
4-2081690-G-C | not specified | Uncertain significance (Jan 26, 2022) | ||
4-2085646-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
4-2085672-T-G | not specified | Uncertain significance (Jul 06, 2022) | ||
4-2085677-A-C | Benign (Dec 31, 2019) | |||
4-2095859-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
4-2095868-G-A | Likely benign (Sep 01, 2022) | |||
4-2095902-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
4-2095912-C-G | not specified | Likely benign (Nov 09, 2021) | ||
4-2095931-T-G | not specified | Uncertain significance (Feb 15, 2023) | ||
4-2128126-G-C | not specified | Uncertain significance (Apr 04, 2023) | ||
4-2128129-T-C | not specified | Uncertain significance (Feb 26, 2024) | ||
4-2128131-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
4-2128206-C-T | not specified | Uncertain significance (Dec 14, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POLN | protein_coding | protein_coding | ENST00000511885 | 24 | 170204 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.49e-41 | 8.74e-8 | 125121 | 0 | 627 | 125748 | 0.00250 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0475 | 481 | 478 | 1.01 | 0.0000248 | 5872 |
Missense in Polyphen | 116 | 127.67 | 0.90858 | 1698 | ||
Synonymous | 0.846 | 168 | 183 | 0.920 | 0.0000102 | 1711 |
Loss of Function | -0.927 | 57 | 49.9 | 1.14 | 0.00000244 | 608 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0112 | 0.0110 |
Ashkenazi Jewish | 0.00357 | 0.00348 |
East Asian | 0.00565 | 0.00562 |
Finnish | 0.00173 | 0.00171 |
European (Non-Finnish) | 0.00177 | 0.00176 |
Middle Eastern | 0.00565 | 0.00562 |
South Asian | 0.00106 | 0.00105 |
Other | 0.00213 | 0.00212 |
dbNSFP
Source:
- Function
- FUNCTION: DNA polymerase with very low fidelity that catalyzes considerable misincorporation by inserting dTTP opposite a G template, and dGTP opposite a T template (PubMed:16787914, PubMed:17118716). Is the least accurate of the DNA polymerase A family (i.e. POLG, POLN and POLQ) (PubMed:17118716). Can perform accurate translesion DNA synthesis (TLS) past a 5S-thymine glycol. Can perform efficient strand displacement past a nick or a gap and gives rise to an amount of product similar to that on non-damaged template. Has no exonuclease activity (PubMed:16787914). Error- prone DNA polymerase that preferentially misincorporates dT regardless of template sequence (PubMed:25775266). May play a role in TLS during interstrand cross-link (ICL) repair (PubMed:19908865). May be involved in TLS when genomic replication is blocked by extremely large major groove DNA lesions. May function in the bypass of some DNA-protein and DNA-DNA cross- links. May have a role in cellular tolerance to DNA cross-linking agents (PubMed:20102227). Involved in the repair of DNA cross- links and double-strand break (DSB) resistance. Participates in FANCD2-mediated repair. Forms a complex with HELQ helicase that participates in homologous recombination (HR) repair and is essential for cellular protection against DNA cross-links (PubMed:19995904). {ECO:0000269|PubMed:16787914, ECO:0000269|PubMed:17118716, ECO:0000269|PubMed:19908865, ECO:0000269|PubMed:19995904, ECO:0000269|PubMed:20102227, ECO:0000269|PubMed:25775266}.;
- Pathway
- Fanconi anemia pathway - Homo sapiens (human);Fanconi Anemia Pathway;DNA Repair;Purine metabolism;Pyrimidine metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.543
- rvis_EVS
- 0.65
- rvis_percentile_EVS
- 84.18
Haploinsufficiency Scores
- pHI
- 0.0656
- hipred
- N
- hipred_score
- 0.457
- ghis
- 0.503
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.542
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Poln
- Phenotype
- cellular phenotype; normal phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- double-strand break repair via homologous recombination;DNA-dependent DNA replication;translesion synthesis;interstrand cross-link repair
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytoplasm
- Molecular function
- DNA binding;DNA-directed DNA polymerase activity;protein binding;cyclin binding